SML0775

PZ-II-029

≥98% (HPLC), a6b3g2/3g2-specific GABAA positive modulator, powder

• Synonym(e): 2,5-Dihydro-7-methoxy-2-(4-methoxyphenyl)-3H-Pyrazolo[4,3-c]quinolin-3-one, 7-Methoxy-2-(4-methoxyphenyl)-2H-pyrazolo[4,3-c]quinolin-3(5H)-one, PZII-029
• Empirische Formel (Hill-System): C₁₈H₁₅N₃O₃
• CAS-Nummer: 164025-44-9
• Molekulargewicht: 321.33
• UNSPSC Code: 12352200
• NACRES: NA.77
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Produktname: PZ-II-029, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to light brown
• solubility: DMSO: 10 mg/mL, clear
• storage temp.: 2-8°C

Beschreibung

Biochem/physiol Actions

PZ-II-029 is an a6b3g2/3g2-specific GABAA positive modulator.

PZ-II-029 is the first compound to be identified as a specific postitive modulator of GABA_A channels composed of α6β3γ2 subunits.

Features and Benefits

This compound is featured on the GABAA Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Sicherheitshinweise

• pictograms: GHS07,GHS09
• signalword: Warning
• hcodes: H302,H410
• pcodes: P264 - P270 - P273 - P301 + P312 - P391 - P501
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1
• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable